References
- Rumgay H, Ferlay J, de Martel C, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108–118.
- Ghavimi S, Apfel T, Azimi H, et al. Management and treatment of hepatocellular carcinoma with immunotherapy: a review of current and future options. J Clin Transl Hepatol. 2020;8(2):168–176.
- Nishikawa H, Kita R, Kimura T, et al. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review. Anticancer Res. 2014;34(12):6877–6886.
- Arizumi T, Ueshima K, Iwanishi M, et al. The overall survival of patients with hepatocellular carcinoma correlates with the newly defined time to progression after transarterial chemoembolization. Liver Cancer. 2017;6(3):227–235.
- Ben-Yosef Y, Miller A, Shapiro S, et al. Hypoxia of endothelial cells leads to MMP-2-dependent survival and death. Am J Physiol Cell Physiol. 2005;289(5):C1321–C1331.
- Gbolahan OB, Schacht MA, Beckley EW, et al. Locoregional and systemic therapy for hepatocellular carcinoma. J Gastrointest Oncol. 2017;8(2):215–228.
- Muddineti OS, Ghosh B, Biswas S. Current trends in using polymer coated gold nanoparticles for cancer therapy. Int J Pharm. 2015;484(1-2):252–267.
- Pan Y, Wu Q, Qin L, et al. Gold nanoparticles inhibit VEGF165-induced migration and tube formation of endothelial cells via the akt pathway. Biomed Res Int. 2014;2014:418624.
- You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano. 2010;4(2):1033–1041.
- Wu J. The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application. J Pers Med. 2021;11(8):771
- Singhana B, Slattery P, Chen A, et al. Light-activatable gold nanoshells for drug delivery applications. AAPS PharmSciTech. 2014;15(3):741–752.
- Han J, Li J, Jia W, et al. Photothermal therapy of cancer cells using novel hollow gold nanoflowers. Int J Nanomed. 2014;9:517–526.
- Tao W, Ji X, Xu X, et al. Antimonene quantum dots: Synthesis and application as near-infrared photothermal agents for effective cancer therapy. Angew Chem Int Ed Engl. 2017;56(39):11896–11900.
- Hainfeld JF, Smilowitz HM, O'Connor MJ, et al. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond). 2013;8(10):1601–1609.
- Gupta S, Stafford RJ, Javadi S, et al. Effects of near-infrared laser irradiation of biodegradable microspheres containing hollow gold nanospheres and paclitaxel administered intraarterially in a rabbit liver tumor model. J Vasc Interv Radiol. 2012;23(4):553–561.
- Yuan H, Li X, Tang J, et al. Local application of doxorubicin-loaded iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats. Cancer Imaging. 2019;19(1):71.
- van Breugel JMM, Geschwind J-F, Mirpour S, et al. Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model. Theranostics. 2019;9(13):3674–3686.
- Zhang LJ, Wu S, Wang M, et al. Quantitative dual energy CT measurements in rabbit VX2 liver tumors: Comparison to perfusion CT measurements and histopathological findings. Eur J Radiol. 2012;81(8):1766–1775.
- Boedtkjer E, Pedersen SF. The acidic tumor microenvironment as a driver of cancer. Annu Rev Physiol. 2020;82:103–126.
- You J, Zhang R, Zhang G, et al. Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: a platform for near-infrared light-trigged drug release. J Control Release. 2012;158(2):319–328.
- Kim W, Cho SK, Shin SW, et al. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy. Abdom Radiol (NY). 2019;44(6):2283–2292.
- El-Agawy W, El-Ganainy SA, Gad MAA, et al. Combined transarterial chemoembolization with microwave ablation versus microwave alone for treatment of medium sized hepatocellular carcinoma. Curr Cancer Drug Targets. 2022;22(1):77–85.
- Li J, Zhou M, Liu F, et al. Hepatocellular carcinoma: Intra-arterial delivery of doxorubicin-loaded hollow gold nanospheres for photothermal ablation-chemoembolization therapy in rats. Radiology. 2016;281(2):427–435.
- Abo-Elfadl MT, Gamal-Eldeen AM, Elshafey MM, et al. Photothermal therapeutic effect of PEGylated gold nano-semicubes in chemically-induced skin cancer in mice. J Photochem Photobiol B. 2016;164:21–29.
- Nault JC, Sutter O, Nahon P, et al. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. J Hepatol. 2018;68(4):783–797.
- Barker HE, Paget JTE, Khan AA, et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409–425.
- Li W, Li X, Liu S, et al. Gold nanoparticles attenuate metastasis by tumor vasculature normalization and epithelial-mesenchymal transition inhibition. Int J Nanomed. 2017;12:3509–3520.
- Darweesh RS, Ayoub NM, Nazzal S. Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications. Int J Nanomed. 2019;14:7643–7663.
- Rambanapasi C, Zeevaart JR, Buntting H, et al. Bioaccumulation and subchronic toxicity of 14 nm gold nanoparticles in rats. Molecules. 2016;21(6):763.
- Sukhanova A, Bozrova S, Sokolov P, et al. Dependence of nanoparticle toxicity on their physical and chemical properties. Nanoscale Res Lett. 2018;13(1):44.